Explore News
-
Why Point-of-Care Testing Matters
Point-of-care testing offers convenient health information for regional communities
-
How Amazon is Changing Diabetes Care
Amazon’s innovative approach to healthcare expands with the introduction of Foundayo
-
10% of People May Not Benefit from GLP-1 Drugs
Emerging research reveals that genetic variation significantly influences how well patients respond to GLP-1 receptor…
-
Mounjaro, Zepbound Cut Heart Disease Death Risk by 22%
New clinical trial data shows GLP-1 medications Mounjaro and Zepbound significantly reduce the risk of…
-
New Ozempic Pill Could Revolutionize Type 2 Diabetes Treatment. Here’s How
Novo Nordisk’s new oral tablet offers a promising alternative for patients
-
Why GLP-1s Don’t Work for All
Groundbreaking research explains inconsistent results of popular diabetes medication
-
Breakthrough in Type 1 Diabetes Research Found
A major step towards a potential cure for type 1 diabetes has been achieved
-
Why a Common Medication May Stop HIV
Researchers discover potential link between diabetes drug and HIV suppression
-
Why Mounjaro Might Cause More Lean Body Mass Loss Than Ozempic
A recent study highlights the potential differences in lean body mass preservation between two popular…
-
Mental Health Support to Be Offered to People with Diabetes in UK First
Charity backs tailored support for diabetes patients
